by Jason Heaviland | Sep 22, 2026
FACS – Cell Sorting Reveals Cell-Specific Metabolic Differences FACS cell sorting can separate defined cell populations before downstream molecular analysis. In this study, Panome Bio used FACS to isolate specific immune cell populations and applied metabolomics...
by Jason Heaviland | Aug 25, 2026
Discovery Exposomics profiling of 30 serum samples identified 240 exposure chemicals, with 138 showing significant differences between Alzheimer’s disease and healthy control groups. The analysis revealed distinct exposure patterns and enrichment across chemical...
by Jason Heaviland | Aug 25, 2026
Targeted Exposomics profiling of 30 serum samples revealed distinct chemical exposure patterns associated with Alzheimer’s disease. Twenty-nine chemical exposures were detected, with several showing significant differences between Alzheimer’s disease and control...
by Jason Heaviland | Aug 4, 2026
Characterizing Chemical Exposures During Pregnancy Through Targeted and Discovery Exposomics™ Exposomics provides a comprehensive approach to characterize exogenous chemical exposures during pregnancy by profiling compounds in maternal and placental samples. In this...
by Jason Heaviland | Jul 10, 2026
This data report demonstrates the capabilities of Panome Bio’s TissueBridge™ FFPE Proteomics, showcasing comprehensive protein profiling from formalin-fixed, paraffin-embedded (FFPE) tissue. The report includes protein identification, differential protein...
